The New Home Company Inc. (NWHM) Analysts See $0.02 EPS; Shorts at Aeterna Zentaris (AEZS) Lowered By 5.35%

The New Home Company Inc. (NYSE:NWHM) Logo

Analysts expect The New Home Company Inc. (NYSE:NWHM) to report $0.02 EPS on July, 26.They anticipate $0.09 EPS change or 81.82% from last quarter’s $0.11 EPS. NWHM’s profit would be $420,159 giving it 125.88 P/E if the $0.02 EPS is correct. After having $-0.03 EPS previously, The New Home Company Inc.’s analysts see -166.67% EPS growth. The stock increased 0.90% or $0.09 during the last trading session, reaching $10.07. About 22,491 shares traded. The New Home Company Inc. (NYSE:NWHM) has declined 7.76% since June 29, 2017 and is downtrending. It has underperformed by 20.33% the S&P500. Some Historical NWHM News: 21/04/2018 – DJ New Home Co Inc, Inst Holders, 1Q 2018 (NWHM); 24/05/2018 – JetBlue Announces Fort Lauderdale as the New Home for Its Travel Products Subsidiary; 11/04/2018 – The New Home Company Announces Marywood Hills, a Collection of Luxury Residences with Unobstructed Views from Orange to the Pacific Ocean; 19/03/2018 – The New Home Company Heads to the Sierra Foothills with Canyon View at Whitney Ranch in Rocklin, California; 03/05/2018 – New Home Sees 2018 Home Sales Rev of $600M-$640M; 24/04/2018 – New Home Short-Interest Ratio Rises 29% to 10 Days; 07/05/2018 – The New Home Company to Webcast Its Presentation at the J.P. Morgan Homebuilding and Building Products Conference; 11/04/2018 – The New Home Company Announces Marywood Hills, a Collection of Luxury Residences with Unobstructed Views from Orange to the; 26/03/2018 – New Home Closes Above 200-Day Moving Average: Technicals; 04/04/2018 – The New Home Company Set to Open First Inland Empire Neighborhood

Aeterna Zentaris Inc (NASDAQ:AEZS) had a decrease of 5.35% in short interest. AEZS’s SI was 565,700 shares in June as released by FINRA. Its down 5.35% from 597,700 shares previously. With 104,200 avg volume, 5 days are for Aeterna Zentaris Inc (NASDAQ:AEZS)’s short sellers to cover AEZS’s short positions. The stock increased 1.52% or $0.03 during the last trading session, reaching $2.01. About 55,886 shares traded. Aeterna Zentaris Inc. (NASDAQ:AEZS) has risen 125.00% since June 29, 2017 and is uptrending. It has outperformed by 112.43% the S&P500. Some Historical AEZS News: 07/05/2018 – AEterna Zentaris 1Q EPS 87c; 19/04/2018 – DJ Aeterna Zentaris Inc, Inst Holders, 1Q 2018 (AEZS); 05/03/2018 – AETERNA ZENTARIS – APPOINTMENT OF JAMES CLAVIJO AS CHIEF FINANCIAL OFFICER EFFECTIVE MARCH 5; 05/03/2018 – AETERNA ZENTARIS INC – CLAVIJO JOINS AETERNA ZENTARIS FROM TRI; 05/03/2018 – AETERNA ZENTARIS INC – CLAVIJO JOINS AETERNA ZENTARIS FROM TRI-SOURCE PHARMA; 07/05/2018 – AEterna Zentaris 1Q Net $14.4M; 08/05/2018 – Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting; 07/05/2018 – AETERNA ZENTARIS INC AEZS.TO – QTRLY SHR $0.87; 28/03/2018 – AEterna Zentaris 4Q Loss/Shr 3c; 05/03/2018 Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer

Among 2 analysts covering Aeterna Zentaris (NASDAQ:AEZS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aeterna Zentaris had 3 analyst reports since March 29, 2018 according to SRatingsIntel. The stock of Aeterna Zentaris Inc. (NASDAQ:AEZS) earned “Buy” rating by H.C. Wainwright on Wednesday, May 9. The stock has “Buy” rating by H.C. Wainwright on Thursday, March 29.

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company has market cap of $34.08 million. The companyÂ’s product pipeline includes Zoptrex, which completed Phase III clinical study for women with advanced, recurrent, or metastatic endometrial cancer, as well as in various phases for the treatment of ovarian and prostate cancer; and MACRILEN, which completed Phase III trial for use in the diagnosis of adult growth hormone deficiency. It has a 19.33 P/E ratio. It is also developing an LHRH-disorazol Z conjugate, which is in pre-clinical development in oncology.

More important recent Aeterna Zentaris Inc. (NASDAQ:AEZS) news were published by: Seekingalpha.com which released: “Key events next week – healthcare” on June 15, 2018, also Nasdaq.com published article titled: “Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH”, Benzinga.com published: “30 Stocks Moving In Thursday’s Pre-Market Session” on June 21, 2018. More interesting news about Aeterna Zentaris Inc. (NASDAQ:AEZS) was released by: Benzinga.com and their article: “58 Biggest Movers From Yesterday” with publication date: June 01, 2018.

The New Home Company Inc., a homebuilder, focuses on the design, construction, and sale of homes in metropolitan areas of California and Arizona. The company has market cap of $211.55 million. The firm operates through two divisions, Homebuilding and Fee Building. It has a 13.43 P/E ratio. It manufactures and sells homes in California, including coastal Southern California, the San Francisco Bay area, the metro Sacramento, and the Phoenix area.

More important recent The New Home Company Inc. (NYSE:NWHM) news were published by: Businesswire.com which released: “The New Home Company Brings National Award-Winning Approach to its Community Design and Development at …” on June 27, 2018, also Ocbj.com published article titled: “Midday Stock Roundup”, Seekingalpha.com published: “Is The New Home Company About To Be Acquired?” on June 28, 2018. More interesting news about The New Home Company Inc. (NYSE:NWHM) was released by: Businesswire.com and their article: “The New Home Company Announces Ellison Park, a Collection of Modern Residences Located in the Heart of the …” with publication date: June 12, 2018.

Among 3 analysts covering The New Home Co Inc (NYSE:NWHM), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. The New Home Co Inc had 3 analyst reports since February 15, 2018 according to SRatingsIntel. The firm earned “Market Perform” rating on Thursday, February 15 by JMP Securities. As per Tuesday, June 19, the company rating was initiated by Citigroup. The firm has “Neutral” rating given on Tuesday, February 20 by JP Morgan.

Investors sentiment decreased to 0.93 in 2018 Q1. Its down 0.61, from 1.54 in 2017Q4. It turned negative, as 7 investors sold The New Home Company Inc. shares while 22 reduced holdings. 9 funds opened positions while 18 raised stakes. 12.29 million shares or 4.54% more from 11.75 million shares in 2017Q4 were reported. Tower Rech Capital Ltd Liability Co (Trc) accumulated 0.01% or 12,869 shares. 610,275 are held by Wells Fargo And Communication Mn. Second Curve Ltd Liability Co, a New York-based fund reported 2.05 million shares. First Tru Advsr Ltd Partnership has 13,226 shares. Amer Intll Gru reported 0% in The New Home Company Inc. (NYSE:NWHM). Pennsylvania-based Brandywine Invest Management Lc has invested 0% in The New Home Company Inc. (NYSE:NWHM). 550,560 are held by Dimensional Fund Advisors Ltd Partnership. Goldman Sachs Gp Inc reported 0% of its portfolio in The New Home Company Inc. (NYSE:NWHM). Ontario – Canada-based Manufacturers Life The has invested 0% in The New Home Company Inc. (NYSE:NWHM). Cidel Asset Mgmt has invested 0.01% in The New Home Company Inc. (NYSE:NWHM). California Employees Retirement Systems has invested 0% in The New Home Company Inc. (NYSE:NWHM). Rhumbline Advisers reported 0% stake. Prudential accumulated 26,052 shares or 0% of the stock. First Manhattan invested in 1.33M shares. Invesco owns 30,835 shares or 0% of their US portfolio.

Since January 2, 2018, it had 0 insider purchases, and 5 sales for $1.39 million activity. $5,856 worth of The New Home Company Inc. (NYSE:NWHM) shares were sold by Davis Joseph David. TCN/TNHC LP also sold $86,040 worth of The New Home Company Inc. (NYSE:NWHM) shares.

The New Home Company Inc. (NYSE:NWHM) Institutional Positions Chart